title: Cervical carcinoma in women less than 35 years of age.
abstract: We retrospectively studied 80 patients, less than 35 years old, who were being treated for invasive cervical carcinoma at Charity Hospital of Louisiana in New Orleans. The period covered by the study was March 1980 to November 1989. The study group represented 9.3% (80/862) of the total patients seen with the disease. Disease stage was IB in 50 patients, IIA in 4, IIB in 14, IIIA in 5, IIIB in 6, and IVA in 1 patient. Histopathologic classes included 74 squamous cell carcinomas, 3 adenosquamous carcinomas, 2 adenocarcinomas, and 1 anaplastic carcinoma. Treatment used was either radical hysterectomy, irradiation alone, or irradiation followed by hysterectomy. Five-year actuarial survival rates were as follows: stage IB, 81.6%; stage IIA, 25.0%; stage IIB, 29.8%; stage IIIA, 20.0%; and stage IIIB, 33.4%. The only patient with stage IV cancer died of disease. Our findings do not reveal a relationship between age and survival in stage IB carcinoma of the cervix, and the numbers in the other stages are too small to comment on.
authors.affiliation: Department of Surgery, Louisiana State University Medical Center, New Orleans.
authors.forename: J P
authors.initials: JP
authors.lastname: Austin
authors.forename: S
authors.initials: S
authors.lastname: Degefu
authors.forename: J
authors.initials: J
authors.lastname: Torres
authors.forename: D J
authors.initials: DJ
authors.lastname: Bush
authors.forename: A G
authors.initials: AG
authors.lastname: O'Quinn
authors.forename: N
authors.initials: N
authors.lastname: Ozmen
authors.forename: J
authors.initials: J
authors.lastname: Rice
mesh_terms: D000328:Adult; D000367:Age Factors; D002294:Carcinoma, Squamous Cell / Q000453:epidemiology / Q000401:mortality / Q000556:secondary / Q000628:therapy; D005260:Female; D006801:Humans; D007044:Hysterectomy; D015994:Incidence; D008145:Louisiana / Q000453:epidemiology; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D012189:Retrospective Studies; D015996:Survival Rate; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000401:mortality / Q000473:pathology / Q000628:therapy